A Chimeric EGFR/neu Receptor in Functional Analysis of the neu Oncoprotein

References

• Schechter A L, Srern D F, Vaidyanathan L., et al. The neu oncogene: an erb-B-related gene encoding a 185 000–M, tumour antigen. Nature 1984; 312: 513–6
   PubMed Web of Science ®Google Scholar
• Padhy L C, Shih C, Cowing D, Finkelstein R, Weinberg R A. Identification of a phosphoprotein specifically induced by the transforming DNA of rat neuroblastomas. Cell 1982; 28: 865–71
   PubMed Web of Science ®Google Scholar
• Akiyama T, Sudo C, Ogawara H, Toyoshima K, Yamamoto T. The product of the human c-erbB-2 gene: A 185–kilodalton glycoprotein with tyrosine kinase activity. Science 1986; 232: 1644–6
   PubMed Web of Science ®Google Scholar
• Bargmann C I, Hung M-C, Weinberg R A. The neu oncogene encodes an epidermal growth factor receptor-related protein. Nature 1986; 319: 226–30
   PubMed Web of Science ®Google Scholar
• Stern D F, Heffernan P A, Weinberg R A. p185, a product of the neu oncogene, is a receptor-like protein associated with tyrosine kinase activity. Mol Cell Biol 1986; 6: 1729–40
   PubMed Web of Science ®Google Scholar
• Di Marco E, Pierce J H, Knicley C L, Di Fiore P P. Transformation of NIH 3T3 cells by overexpression of the normal coding sequence of the rat neu gene. Mol Cell Biol 1990; 10: 3247–52
   PubMed Web of Science ®Google Scholar
• Bargmann C I, Hung M-C, Weinberg R A. Multiple independent activations of the neu oncogene by a point mutation altering the transmembrane domain of p185. Cell 1986; 45: 649–51
   PubMed Web of Science ®Google Scholar
• Shih C, Padhy L C, Murray M, Weinberg R A. Transforming gene from neuroblastomas introduced into mouse fibroblasts. Nature 1981; 290: 261–3
   PubMed Web of Science ®Google Scholar
• Stern D F, Kamps M P, Cao H. Oncogenic activation of pl 85new stimulates tyrosine phosphorylation in vivo. Mol Cell Biol 1988; 8: 3969–73
   PubMed Web of Science ®Google Scholar
• Segatto O, King C R, Pierce J H, Di Fiore P P, Aaronson S A. Different structural alterations upregulate in vitro tyrosine kinase activity and transforming potency of the erbB-2 gene. Mol Cell Biol 1988; 12: 5570–4
   Google Scholar
• Bargmann C I, Weinberg R A. Oncogenic activation of the neu-encoded receptor protein by point mutation and deletion. EMBO J 1988; 7: 2043–52
   PubMed Web of Science ®Google Scholar
• Muller W, Sinn E, Pattengale P K, Wallace R, Leder P. Single step induction of mamary adenocarcinoma in transgenic mice bearing the activated c-neu oncogene. Cell 1988; 54: 105–15
   PubMed Web of Science ®Google Scholar
• Bouchard L, Lamarre L, Tremblay P J, Jolicoeur P. Stochastic appearance of mamary tumours in transgenic mice carrying the MMTV/c-neu oncogene. Cell 1989; 57: 931–6
   PubMed Web of Science ®Google Scholar
• Slamon D J, Clark G M, Wong S G, Levin W J, Ullrich A, McGuire W L. Human breast cancer: correlation of relapse and survival with amplification of the HER-Z/neu oncogene. Science 1987; 235: 177–82
   PubMed Web of Science ®Google Scholar
• Slamon D J, Godolphin W, Jones L A, et al. Studies of the HER-Z/neu proto-oncogene in human breast and ovarian cancer. Science 1989; 244: 707–12
   PubMed Web of Science ®Google Scholar
• Venter D J, Kumar S, Tuzi N L, Gullick W J. Overexpression of the c-erbB-2 oncoprotein in human breast carcinomas: immunohistological assesment correlates with gene amplification. Lancet 1987; 2: 69–71
   PubMed Web of Science ®Google Scholar
• van de Vivjer M., Peterse J L, Moor W J, et al. neu-protein with comedo-type ductal carcinoma in situ and limited prognostic value in stage II breast cancer. N Engl J Med 1988; 319: 1239–45
   PubMedGoogle Scholar
• Lehväslaiho H, Lehtola L, Sistonen L, Alitalo K. A chimeric EGFR/neu proto-oncogene allows EGF to regulate neu tyrosine kinase and cell transformation. EMBO J 1989; 8: 159–66
   PubMedGoogle Scholar
• Wada T, Qian X, Greene M I. Intermolecular association of the p185neu protein and EGF receptor function. Cell 1990; 61: 1339–47
   PubMed Web of Science ®Google Scholar
• Stern D F, Kamps M P. EGF-stimulated tyrosine phosphrylation of p185neu: a potential model for receptor interactions. EMBO J 1988; 7: 995–1001
   PubMed Web of Science ®Google Scholar
• King C R, Borello I, Bellot F, Comoglio P, Schlessinger J. EGF binding to its receptor triggers a rapid tyrosine phosphorylation of the erbB-2 protein in the mammary tumor cell line SK-BR-3. EMBO J 1988; 7: 1647–51
   PubMed Web of Science ®Google Scholar
• Kokai Y, Dobashi K, Weiner D B, Myers J N, Nowell P C, Greene M I. Phosphorylation process induced by epidermal growth factor alters the oncogenic and cellular neu (NGL) gene products. Proc Natl Acad Sci USA 1988; 85: 5389–93
   PubMedGoogle Scholar
• Kokai Y, Myers J N, Wada T, et al. Synergistic interaction of p185c-neu and the EGF receptor leads to transformation of rodent fibroblasts. Cell 1989; 58: 287–92
   PubMed Web of Science ®Google Scholar
• Wada T, Myers J N, Kokai Y, et al. Anti-receptor antibodies reverse the phenotype of cells transformed by two interacting proto-oncogene encoded receptor proteins. Oncogene 1990; 5: 489–95
   PubMedGoogle Scholar
• Lehtola L, Lehväslaiho H, Sistonen L, Beguinot L, Alitalo K. Receptor downregulation and DNA synthesis are modulated by EGF and TPA in cells expressing an EGFR/neu chimera. Growth Factors 1989; 1: 323–34
   PubMedGoogle Scholar
• Pandiella A, Lehväslaiho H, Magni M, Alitalo K, Meldolesi J. Activation of an EGFR/neu chimeric receptor: early intra-cellular signals and cell proliferation responses. Oncogene 1989; 4: 1299–305
   PubMedGoogle Scholar
• Lehväslaiho H, Sistonen L, Lehtola L, et al. Regulation by EGF is maintained in an overexpressed chimeric EGFR/neu receptor tyrosine kinase. J Cell Biochem 1990; 42: 123–33
   PubMedGoogle Scholar
• Hung M-C, Schechter A L, Chevray P-Y, Stem D F, Weinberg R A. Molecular cloning of the neu gene: absence of gross structural alteration in oncogenic alleles. Proc Natl Acad Sci USA 1986; 83: 261–4
   PubMedGoogle Scholar
• Lee J, Dull T J, Lax I, Schlessinger J, Ullrich A. HER2 cytoplasmic domain generates normal mitogenic and transforming signals in a chimeric receptor. EMBO J 1989; 8: 167–73
   PubMed Web of Science ®Google Scholar
• Gullick W J, Berger M S, Bennett P LP, Rothbard J B, Waterfield M D. Expression of the c-erbB-2 protein in the normal and transformed cells. Int J Cancer 1987; 40: 246–54
   PubMed Web of Science ®Google Scholar
• Heine U I, Keski-Oja J, Wetzel B. Rapid membrane changes in mouse epithelial cells after exposure to epidermal growth factor. J Ultrasturct Res 1981; 77: 335–43
   PubMedGoogle Scholar
• Beguinot L, Lyall R M, Willingham M C, Pastan I. Down-regulation of the epidermal growth factor receptor in KB cells is due to receptor internalization and subsequent degradation in lysosomes. Proc Natl Acad Sci USA 1984; 81: 2384–8
   PubMed Web of Science ®Google Scholar
• Beguinot L, Hanover J A, Ito S, Richert N D, Willingham M C, Pastan I. Phorbol esters induce transient internalization without degradation of unoccupied epidermal growth factor receptors. Proc Natl Acad Sci USA 1985; 82: 2774–8
   PubMedGoogle Scholar
• Pandiella A, Beguinot L, Velu T J, Melodlesi J. Transmembrane signalling at epidermal growth factor receptors overexpressed in NIH3T3 cells. Phosphoinositide hydrolysis, cytosolic Ca2 + increase and alkalinization correlate with epidermal-growth-factor-induced cell proliferation. Biochem J 1988; 254: 223–8
   PubMedGoogle Scholar